| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Terns Pharmaceuticals, Inc. (TERN) has 9 insiders with recent SEC Form 4 filings, including 5 buys and 0 sells. TERN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 984.7K | - | - | |
| Other | 106.6K | - | - | |
| CFO | 101.8K | - | - | |
| Dir | 2.8K | - | - | |
| Dir | 1.7K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2021 | Orbimed Advisors LLC66 | Director, 10% Owner | Buy | 475,000 | $17.00 | $8,075,000.00 | +14.3% | |
| Feb 9, 2021 | Vivo Capital Viii, LLC57 | 10% Owner | Buy | 475,000 | $17.00 | $8,075,000.00 | +21.6% |